🔎 Trials Near Me

Gara Jalqabaatti › Diffuse Large B-Cell Lymphoma › New York

Qorannoo klinikaalii Diffuse Large B-Cell Lymphoma New York keessatti

Qorannoo 31 Diffuse Large B-Cell Lymphoma f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Columbia University Medical Center, New York
  • Weill Cornell Medical College Newyork Presbyterian Hospital, New York
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

  • Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York
  • University of Rochester Medical Center, Rochester
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06500273

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

  • Roswell Park Cancer Institute, Buffalo
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06863402

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

  • Roswell Park Cancer Institute, Buffalo
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06649812

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  • New York Medical College ( Site 0113), Valhalla
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05139017

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  • New York Oncology Hematology, P.C. ( Site 0129), Albany
  • Icahn School of Medicine at Mount Sinai ( Site 0164), New York
  • New York Cancer and Blood Specialists ( Site 9000), Shirley
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06717347

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

  • Roswell Park Cancer Institute ( Site 0192), Buffalo
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0208), Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0108), New York
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06890884

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  • Stony Brook University Hospital, Stony Brook
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06091865

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • New York University (NYU) Clinical Cancer Center, New York
  • Weill Cornell Medicine, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  • Columbia University, New York
  • University of Rochester, Rochester
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07226843

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Memorial Sloan Kettering Cancer Center ( Site 1010), New York
  • New York Medical College ( Site 1023), Valhalla
Namoota walitti qabaa jiraSadarkaa 1/2
6 Months – 25 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06395103

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • Memorial Sloan Kettering Cancer Center, New York
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07195916

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

  • New York Oncology Hematology, P.C., Albany
  • Hematology Oncology Associates of Central New York, East Syracuse
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06806033

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

  • NYU Langone Hospital - Long Island, Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT05272384

A Study of ARC-02 in B-cell NHL

  • NYU Langone, New York
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • New York Medical College, Valhalla
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Roswell Park Comprehensive Cancer Center, Buffalo
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 65 hanga 80 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06765317

DALY II USA/ MB-CART2019.1 for DLBCL

  • Memorial Sloan Kettering Cancer Center, New York
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center - Moses Campus, The Bronx
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT05077527

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

  • New York Medical Center, Valhalla
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 70 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04491370

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT04512716

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • University of Rochester, Rochester
  • Wilmot Cancer Institute at Webster, Webster
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Gur-2026 · NCT05633615

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

  • Columbia University, New York
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ama-2026 · NCT06693830

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Mud-2025 · NCT06736613

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • University of Rochester, Rochester
  • Wilmot Cancer Institute at Webster, Webster
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Onk-2025 · NCT05890352

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

  • Memorial Sloan Kettering Cancer Center (All protocol activities), New York
  • NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Onk-2025 · NCT05940272

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

  • New York Medical College, Valhalla
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 3 hanga 31 · Saalaa hunda · Haaromfame 08-Hag-2025 · NCT02393157

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

  • Memorial Sloan Kettering Cancer Center, New York
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Ful-2024 · NCT06238648

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.